Journal
CELL SYSTEMS
Volume 11, Issue 4, Pages 393-+Publisher
CELL PRESS
DOI: 10.1016/j.cels.2020.08.012
Keywords
-
Categories
Funding
- Gattuso Slaight Personalized Cancer Medicine Fund at Princess Margaret Cancer Centre
- Canadian Institute of Health Research
- Natural Sciences and Engineering Research Council
- Stand Up To Cancer Canada
Ask authors/readers for more resources
Genomic instability affects the reproducibility of experiments that rely on cancer cell lines. However, measuring the genomic integrity of these cells throughout a study is a costly endeavor that is commonly forgone. Here, we validate the identity of cancer cell lines in three pharmacogenomic studies and screen for genetic drift within and between datasets. Using SNP data from these datasets encompassing 1,497 unique cell lines and 63 unique pharmacological compounds, we show that genetic drift is widely prevalent in almost all cell lines with a median of 4.5%-6.1% of the total genome size drifted between any two isogenic cell lines. This study highlights the need for molecular profiling of cell lines to minimize the effects of passaging or misidentification in biomedical studies. We developed the CCLid web application, available at www.cclid.ca, to allow users to screen the genomic profiles of their cell lines against these datasets. A record of this paper's transparent peer review process is included in the Supplemental Information.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available